Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

[++UKPDS Study. Metformin in obese patients with Type 2 diabetes (UKPDS 340].

Janka HU.

Internist (Berl). 2000 Jul;41(7):688-9. Review. German. No abstract available.

PMID:
10929259
3.

Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No. 51).

Clarke P, Gray A, Adler A, Stevens R, Raikou M, Cull C, Stratton I, Holman R; UKPDS Group. United Kingdom Prospective Diabetes Study.

Diabetologia. 2001 Mar;44(3):298-304.

PMID:
11317659
4.

Improving survival with metformin: the evidence base today.

Scarpello JH.

Diabetes Metab. 2003 Sep;29(4 Pt 2):6S36-43. Review.

PMID:
14502099
5.

Some answers, more controversy, from UKPDS. United Kingdom Prospective Diabetes Study.

Nathan DM.

Lancet. 1998 Sep 12;352(9131):832-3. No abstract available.

PMID:
9742972
7.

[Current role of metformin in treatment of diabetes mellitus type 2].

Janssen JA.

Ned Tijdschr Geneeskd. 2000 Sep 30;144(40):1900-2. Review. Dutch.

PMID:
11045135
8.

[United Kingdom Prospective Diabetes Study (UKPDS): 10 years later].

Scheen AJ, Paquot N, Lefebvre PJ.

Rev Med Liege. 2008 Oct;63(10):624-9. French.

9.
10.

[Metformin and type 2 diabetes: the UKPDS experience].

Leverve XM.

Journ Annu Diabetol Hotel Dieu. 2007:5-11. French. No abstract available.

PMID:
18610755
11.

The continuing legacy of the United Kingdom Prospective Diabetes Study.

Davis TM, Colagiuri S; United Kingdom Prospective Diabetes Study.

Med J Aust. 2004 Feb 2;180(3):104-5. No abstract available.

PMID:
14748669
12.

[Should the occurrence of a first coronary event change the management of diabetes?].

Timsit J, Dubois-Laforgue D.

Arch Mal Coeur Vaiss. 2000 Dec;93 Spec No 4:39-44. Review. French.

PMID:
11296461
13.

[Drug treatment of type 2 diabetes].

Plank J, Bock GM.

Wien Med Wochenschr. 2003;153(21-22):452-8. Review. German.

PMID:
14679886
14.

[Impact of intensive blood glucose control with hypoglycemic sulfamides, metformin or insulin on complications of non-insulin dependent diabetes].

André P.

Rev Epidemiol Sante Publique. 1999 Mar;47(1):93-5. French. No abstract available.

PMID:
10214683
15.
18.

Addition of rosiglitazone to metformin is most effective in obese, insulin-resistant patients with type 2 diabetes.

Jones TA, Sautter M, Van Gaal LF, Jones NP.

Diabetes Obes Metab. 2003 May;5(3):163-70.

PMID:
12681023
19.

Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin.

Miles JM, Leiter L, Hollander P, Wadden T, Anderson JW, Doyle M, Foreyt J, Aronne L, Klein S.

Diabetes Care. 2002 Jul;25(7):1123-8. Erratum in: Diabetes Care. 2002 Sep;25(9):1671..

PMID:
12087008
20.

Type 2 diabetes: target HbA1c of about 7%.

[No authors listed]

Prescrire Int. 2009 Aug;18(102):177.

PMID:
19746575

Supplemental Content

Support Center